Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01699867 · ClinicalTrials.gov registry record

Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part A)

A clinical trial of Breast Cancer, sponsored by Diagnostic Photonics.

Completed
Registry status
50
Enrollment target
2
Study locations

NCT01699867: Completed study of Breast Cancer, sponsored by Diagnostic Photonics.

NCT01699867 is a study of Breast Cancer that has completed, run by Diagnostic Photonics. The registered enrollment target is 50 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01699867, a study of Breast Cancer, has completed, sponsored by Diagnostic Photonics.

COMPLETED
Registry status
50 participants
Enrollment target
2
Study locations

Study Summary

This multi-center, prospective, open label study analyzed specimens from fifty subjects at two study sites. Patients scheduled to undergo breast-conserving surgery were recruited in accordance with the inclusion and exclusion criteria. The study period per subject was the time it took to assess the ex vivo breast tissue sample using the study device. Image review was conducted after surgery and compared to the margin status findings in the post-operative pathology report.

Primary Outcome

In this study, a patient had "positive margins" if tumor was identified at the true margin (i.e., the final margin or new margin) surface of at least one specimen by histology (0 mm, "tumor on ink").

Conditions Studied

Breast Cancer

Interventions

  • DEVICE Optical coherence tomography

Study Locations (2)

Maryland

  • Anne Arundel Medical Center - Annapolis
  • Johns Hopkins Hospital - Baltimore

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2012-12
Est. Completion 2014-04
Diagnostic Photonics

2 total trials

What the finished NCT01699867 record still lists

NCT01699867 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Optical coherence tomography is the first listed.

NCT01699867 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT01699867 about?

NCT01699867 is a clinical study titled "Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part A)". This multi-center, prospective, open label study analyzed specimens from fifty subjects at two study sites. Patients scheduled to undergo breast-conserving surgery were recruited in accordance with the inclusion and exclusion criteria. The study period per subject was the time it took to assess the ...

What is the current status of trial NCT01699867?

This trial is currently completed. The enrollment target is 50 participants. The study started on 2012-12. Estimated completion is 2014-04.

What conditions does trial NCT01699867 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT01699867?

The interventions under investigation include: Optical coherence tomography (DEVICE).

Who is sponsoring clinical trial NCT01699867?

This trial is sponsored by Diagnostic Photonics, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01699867 being conducted?

This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01699867's enrollment target sits among peer trials

50 789th of 1224 higher than 410 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT01699867, the US trial registry maintained by the National Library of Medicine. NCT01699867 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.